Objective: To develop and validate a predictive model for acquiring sexually transmitted infections (STIs) in individuals using HIV pre-exposure prophylaxis (PrEP) within the national program providing this strategy. Methods: Ambispective cohort study, multicentric (23 Spanish hospitals). All PrEP users, with follow-up within the program, will be included. Entry into the program will be considered as the baseline visit. From there, patients are followed quarterly, following the national protocols for monitoring PrEP users in Spain. At each visit, diagnosis of different STIs (serum, pharyngeal swab, urethral or urine sample, rectal swab, endocervical/vaginal swab, ulcer) is performed. Primary outcome variable: development of an STI (Yes/No). The following STIs will be considered: syphilis, Neisseria gonorrhoeae (NG) infection, Chlamydia trachomatis (CT) infection, lymphogranuloma venereum (LGV), Mycoplasma genitalium (MG) infection, genital herpes, hepatitis A, hepatitis B, hepatitis C, HIV infection, and MPOX. Secondary outcome variable: number of diagnosed STIs. In order to determine factors associated with acquiring an STI, multivariate analyses will be conducted using logistic regression. The best models will be analyzed in the validation population. To compare the models, we will follow the Bayesian approach suggested by Benavoli et al.
Study Type
OBSERVATIONAL
Enrollment
9,000
No Intervention: Observational Cohort
Hospital Universitario de Torrecárdenas
Almería, Spain
RECRUITINGHospital Universitario Puerto Real
Cadiz, Spain
RECRUITINGHospital Universitario Santa Lucía
Cartagena, Spain
RECRUITINGhospital Universitario reina Sofía
Córdoba, Spain
RECRUITINGHospital Virgen de la Luz
Cuenca, Spain
RECRUITINGHospital Universitario de Elche
Elche, Spain
RECRUITINGHospital Clínico Universitario San Cecilio
Granada, Spain
RECRUITINGHospital Universitario Virgen de las Nieves
Granada, Spain
RECRUITINGHospital Universitario Juan Ramón Jiménez
Huelva, Spain
RECRUITINGComplejo Hospitalario de Jaén
Jaén, Spain
RECRUITING...and 16 more locations
STI predictive model
Predictive model for the acquisition of sexually transmitted infections in individuals using PrEP within the national provision program for this strategy
Time frame: through study completion, an average of 5 years
STI incidence
Incidence of sexually transmitted infections (STIs) in the cohort globally and by type of infection.
Time frame: through study completion, an average of 5 years
STI dynamics
Evolution of STI diagnoses during follow-up among PrEP users included in the study, both globally and by specific pathogen
Time frame: through study completion, an average of 5 years
asymptomatic STIs
Proportion of asymptomatic STIs diagnosed within the screening program.
Time frame: through study completion, an average of 5 years
behavioral changes
Sexual risk behaviors of individuals in the cohort, before and after initiating PrEP
Time frame: through study completion, an average of 5 years
DOXYPEP
Proportion of Individuals who might benefit from the 'Doxy-PEP' strategy (doxycycline use as post-exposure prophylaxis for chlamydia and syphilis)
Time frame: through study completion, an average of 5 years
PrEP discontinuation
Prevalence of oral PrEP discontinuation within a nationwide PrEP users' cohort.
Time frame: through study completion, an average of 5 years
Predictor of PrEP discontinuation
Predictors of oral PrEP discontinuation within a nationwide PrEP users' cohort.
Time frame: through study completion, an average of 5 years
PrEP adherence
Self-reported oral PrEP adherence.
Time frame: through study completion, an average of 5 years
Time to discontinuation
Time elapsed between oral PrEP initiation and oral PrEP discontinuation.
Time frame: through study completion, an average of 5 years
HIV incident infection
Incidence of HIV seroconversions
Time frame: through study completion, an average of 5 years
HIV incident infection
Profiles of those who acquire HIV while taking oral PrEP.
Time frame: through study completion, an average of 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.